Details for Patent: 10,213,400
✉ Email this page to a colleague
Which drugs does patent 10,213,400 protect, and when does it expire?
Patent 10,213,400 protects XYREM and XYWAV and is included in two NDAs.
Protection for XYREM has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has thirty-three patent family members in twenty-one countries.
Summary for Patent: 10,213,400
| Title: | Method of administration of gamma hydroxybutyrate with monocarboxylate transporters |
| Abstract: | One embodiment of the present invention is to improve the safety and efficacy of the administration of GHB or a salt thereof to a patient. It has been discovered that the concomitant administration of an MCT inhibitor, such as diclofenac, valproate, or ibuprofen, will affect GHB administration. For example, it has been discovered that diclofenac lowers the effect of GHB in the body, thereby potentially causing an unsafe condition. Furthermore, it has been discovered that valproate increases the effect of GHB on the body, thereby potentially causing an unsafe condition. |
| Inventor(s): | Eller; Mark (Redwood City, CA) |
| Assignee: | JAZZ PHARMACEUTICALS IRELAND LIMITED (Dublin, IE) |
| Application Number: | 15/869,792 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 10,213,400 |
|
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 10,213,400
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jazz Pharms | XYREM | sodium oxybate | SOLUTION;ORAL | 021196-001 | Jul 17, 2002 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| Jazz | XYWAV | calcium oxybate; magnesium oxybate; potassium oxybate; sodium oxybate | SOLUTION;ORAL | 212690-001 | Jul 21, 2020 | RX | Yes | Yes | ⤷ Sign Up | ⤷ Sign Up | Y | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 10,213,400
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2014223373 | ⤷ Sign Up | |||
| Brazil | 112015021012 | ⤷ Sign Up | |||
| Canada | 2902948 | ⤷ Sign Up | |||
| China | 105073106 | ⤷ Sign Up | |||
| China | 111317730 | ⤷ Sign Up | |||
| Cyprus | 1120086 | ⤷ Sign Up | |||
| Cyprus | 1122992 | ⤷ Sign Up | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
